Advertisement

Topics

Investors Flock To Gene-Editing Tool, Even Though No One Knows Who Owns It Yet

09:17 EDT 23 Sep 2016 | Kaiser Health News

Crispr-Cas9 is embroiled in a high-stakes patent dispute for control over groundbreaking technology that can cut DNA and make repairs or changes to genes. But that hasn't stopped companies from launching development programs that would use the tool.

Original Article: Investors Flock To Gene-Editing Tool, Even Though No One Knows Who Owns It Yet

NEXT ARTICLE

More From BioPortfolio on "Investors Flock To Gene-Editing Tool, Even Though No One Knows Who Owns It Yet"

Quick Search
Advertisement
 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...